If, however, a mouse had a second, similarly sized, untreated tumor on the opposite flank, the ability of CpG + OX40 to cure the local ~ 350 mm3 treated tumor was reduced (Fig. 2d, E vs Fig. 4g,i). This evidence concerns the gene TNFRSF4 and neoplasm.